Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss

por Fearon, U, Mullan, R, Poole, R, Markham, T, FitzGerald, O, Bresnihan, B, Veale, DJ
Publicado 2005

Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors

por Gao, W, McGarry, T, Orr, C, McCormick, J, Veale, D J, Fearon, U
Publicado 2016

Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis

por Fromm, S., Cunningham, C. C., Dunne, M. R., Veale, D. J., Fearon, U., Wade, S. M.
Publicado 2019

The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis

por Mullan, RH, Lobanok, T, Walsh, C, King, L, FitzGerald, O, Bresnihan, B, Fearon, U, Poole, R, Veale, DJ
Publicado 2005

Synovial tissue hypoxia and inflammation in vivo

por Ng, C T, Biniecka, M, Kennedy, A, McCormick, J, FitzGerald, O, Bresnihan, B, Buggy, D, Taylor, C T, O'Sullivan, J, Fearon, U, Veale, D J
Publicado 2010

Dysregulated bioenergetics: a key regulator of joint inflammation

por Biniecka, M, Canavan, M, McGarry, T, Gao, W, McCormick, J, Cregan, S, Gallagher, L, Smith, T, Phelan, J J, Ryan, J, O'Sullivan, J, Ng, C T, Veale, D J, Fearon, U
Publicado 2016